ClinVar Miner

Submissions for variant NM_000238.3(KCNH2):c.2320G>T (p.Asp774Tyr) (rs199472995)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Blueprint Genetics, RCV000208316 SCV000263981 pathogenic Long QT syndrome 2 2015-04-20 criteria provided, single submitter clinical testing
Cardiovascular Biomedical Research Unit,Royal Brompton & Harefield NHS Foundation Trust RCV000058106 SCV000089626 not provided Congenital long QT syndrome no assertion provided literature only This variant has been reported as associated with Long QT syndrome in the following publications (PMID:15840476;PMID:17905336;PMID:19716085;PMID:22429796). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory.
GeneDx RCV000182045 SCV000234348 likely pathogenic not provided 2017-05-10 criteria provided, single submitter clinical testing The D774Y likely pathogenic variant in the KCNH2 gene has been reported previously in multiple unrelated patients with LQTS and has not been detected in over 1,500 reference alleles (Tester et al., 2005; Chung et al., 2007; Kapplinger et al, 2009). In addition, Obeyesekere et al. (2012), observed the D774Y variant in three individuals with a history of sudden cardiac death and prolonged end-recovery QTc.D774Y occurs in the S6/cyclic nucleotide-binding domain of the resultant protein, where many other pathogenic missense variants have been reported in association with LQTS (Stenson et al., 2014). According to the NHLBI Exome Sequencing Project, D774Y was not observed in approximately 6,500 individuals from European and African American backgrounds, indicating that it is not a common variant in these populations. In silico analysis predicts this variant is probably damaging to the protein structure/function. Nevertheless, the D774Y variant results in a conservative amino acid substitution, which is not likely to impact secondary structure as these residues share similar properties.In summary, the D774Y variant is a strong candidate to be pathogenic

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.